| Authors: |
Yerram NK; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Long L; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., O'Connor LP; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wang AZ; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ahdoot M; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Lebastchi AH; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Gurram S; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Zeng J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Chalfin H; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Harmon SA; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland., Mehralivand S; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Merino MJ; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Parnes HL; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choyke PL; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Shih J; Division of Cancer Prevention, National Cancer Institutes, National Institutes of Health, Bethesda, Maryland., Wood BJ; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Turkbey B; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Pinto PA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. |